Back

Evaluation of the disease-modifying effects of Aureobasidium pullulans AFO-202 strain produced Beta-Glucan in Parkinsons disease - Results of a pilot clinical study

2023-04-19 neurology Title + abstract only
View on medRxiv
Show abstract

The aetiology of Parkinsons disease (PD) has been linked to the aggregation and spread of misfolded alpha-synuclein via the gut-brain axis. We previously reported the effects of a biological response modifier, beta-glucan, produced by the AFO-202 strain of Aureobasidium Pullulans, which improves clinical symptoms and controls gut Enterobacteriaceae associated with curli and amyloid-alpha-synuclein production. In this study, we report the effects of beta-glucan on PD. Eight patients with PD were ...

Predicted journal destinations